Tero Jormanainen

Tero is recognized as one of the leading experts in his field by international directories such as Chambers Europe, Chambers Global and IFLR1000 within corporate/M&A in Finland.

This is what clients say about Tero:

“Tero Jormanainen is an amazing lawyer for M&A processes. His role in the negotiation process is very important and very much solution-driven.”
– Chambers Global 2024, Corporate/M&A

“Mr Jormanainen delivers sophisticated, tailor-made solutions.”
– Chambers Global 2024, Corporate/M&A

“He is a go-to person for complex transactions.”
– Chambers Global 2024, Corporate/M&A

“Tero is a very constructive lawyer to work with.”
– Chambers Global 2024, Corporate/M&A

“He is very efficient, to the point and commercial.”
– Chambers Global 2024, Corporate/M&A

“Tero Jormanainen is a great communicator and has the ability to make any circumstances feel straightforward and simple despite the deal complexity.”
– The Legal 500 2024, Commercial, Corporate and M&A

“Tero Jormanainen is extremely good in the M&A processes and related negotiations. He is very much solution-orientated and adapts well in the position the customer has in the negotiations.”
– IFLR1000 2023/2024 (33rd edition)

“He is a great negotiator.”
– Chambers Global 2023, Corporate/M&A

“Tero Jormanainen – highly pragmatic and friendly approach even in substantially complex situations. Highly respected and trusted by our team.”
– The Legal 500 2023, Commercial, Corporate and M&A

“He sees the big picture and what is relevant, and his ability to effectively get the deal over the finish line is phenomenal.”
– Chambers Global 2022, Corporate/M&A

Tero Jormanainen’s experience includes advising:

• ŌURA in the acquisition of Human Engineering Health Oy, a startup behind the metabolic health product Veri;
• Advanced Micro Devices, Inc. in acquisition of Silo AI Oy;
• Solidium in convertible bond investment in satellite imaging company ICEYE;
• European Directories Group, a portfolio company owned by Triton, in the sale of Fonecta Group to Sponsor Capital;
• Metacore Games Oy in the acquisition of PinataHEL Oy;
• Roblox Corporation in the acquisition of Speechly;
• Warburg Pincus in the acquisition of Epassi Group;
• Nordic Mezzanine Fund II and other shareholders in the sale of Sauna360 group of companies to Masco;
• Oura Health Oy in its acquisition of Proxy Inc;
• TILT Biotherapeutics in connection with their EUR 22 million financing round;
• Klett Lernen und Information GmbH in the acquisition of the majority shareholding in Studeo Oy;
• Folmer in the acquisition of a majority stake in REACHLaw Ltd;
• Wolt in the EUR 7 billion sale of the company to DoorDash;
• Mobidiag and its shareholders in the EUR 668 million sale of the company to Hologic, Inc;
• Thermacell Repellents, Inc. in its acquisition of the majority of the shares in Proviter Oy;
• DevCo Partners Oy in DevCo’s investment in technology manufacturer Bluefors Oy;
• The shareholders in the sale of Relax Gaming to Kindred Group;
• Orkla ASA in the acquisition of NutraQ 2 AS, a leading supplier of health and beauty products within the two well-known health and beauty concepts VitaePro and Oslo Skin Lab;
• Wolt in its EUR 440 million financing round;
• The Sellers in the sale of Fourkind Global Oy to ThoughtWorks Holdings Finland Oy;
• Volpi Capital in the management buyout of Profit Holding Oy;
• Folmer Equity Fund II Ky and Holmberg Brands Oy in the acquisition of a majority stake in Nanso Group;
• Varjo Technologies Oy in its series C financing round;
• Goldman Sachs International as Finnish law counsel in its investment in Wolt Enterprises Oy;
• Elekta AB in the acquisition of Kaiku Health Oy;
• Quest Diagnostics in the acquisition of Blueprint Genetics;
• VMP Plc in the merger of VMP and Smile Henkilöstöpalvelut Oyj;
• Posti Group Corporation in the sale of OpusCapita Solutions Oy to a fund managed by Providence Equity Partners L.L.C.;
• Humana AB in its acquisition of all shares in Coronaria Hoiva Oy from Coronaria Oy;
• Funds managed by KKR and Triton in the sale of Mehiläinen Group;
• Funds managed by Axcel Management A/S in the EUR 163 million acquisition of Orion Diagnostica Oy;
• Funds advised by Sentica Partners in the acquisition of a majority stake in VMP Group;
• YIT Corporation in its combination with Lemminkäinen.

Roschier (2008-), Partner since 2014
Freshfields Bruckhaus Deringer LLP /London, Visiting Lawyer (2011-2012)
KONE Corporation, Legal Counsel (2007-2008)
Roschier, Associate Lawyer (2004-2006)

Member of the Finnish Bar Association

University of Turku, LL.M. (2004)
University of Turku, M.Sc. (Pol.) (2002)

English, Finnish, Swedish